Sonpiretigene isteparvovec is the nonproprietary name for MOGENRY, formerly referred to in trials as MCO-010. It is built on ...

Retina Consultants of America (RCA) recently released its first State of Retina Care report—a survey-based assessment of the pressures facing community-based retina practices and of how affiliated ...

ESCRS 2026 data: patient selection and education may be key to aceclidine (VIZZ; LENZ Therapeutics) persistence. Romero emphasized that use of the drops is task-specific rather than a continuous ...

The first patients were dosed in the global phase 3 ORBIT pivotal trial of linsitinib for thyroid eye disease (TED). The first patients were dosed in the global phase 3 ORBIT trial evaluating ...

Mingo Botín, MD, PhD, discusses ESCRS 2026 data on an EDOF IOL in post-LASIK eyes vs non-LASIK controls.

Alessandro Arrigo, MD, previews an ESCRS 2026 presentation on a patent-pending method that adapts blue light autofluorescence ...

In an interview at the 44th Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held September ...

Q3 2026 delivered advances in some closely watched pipeline products.

After four years and 500+ office-based procedures, Johnathan Feistmann, MD, shares how the model shortened time to surgery for fovea-threatening cases while reshaping patient experience and practice ...

Mfazo Hove, MD, FRCOphth, a consultant ophthalmologist based in London, has a personal perspective on the trifocal ...

Artificial intelligence (AI) is set to reshape multiple corners of eye care, according to Jai Parekh, MD, MA, FAAO, who ...